Takeda Pharmaceutical Company
Access to Medicines Update 2023
Pages
11
Time to read
17 mins
Publication
Language
English
Pages
11
Time to read
17 mins
Publication
Language
English
This document is an update report on access to medicines for the year 2023. It outlines the critical need for equitable access to healthcare, especially for underserved populations. The report emphasizes the importance of addressing barriers to access, including affordability and local healthcare system challenges. It describes the implementation of Patient Assistance Programs (PAPs) in various countries, including Vietnam and Mexico, aimed at providing financial support to patients who cannot afford treatment. The report also details partnerships with governments and healthcare organizations to enhance access to innovative medicines and improve health outcomes. It highlights the ongoing efforts to strengthen local healthcare systems and the importance of collaboration with local authorities and stakeholders. The document concludes by reaffirming the commitment to sustainable and equitable access to healthcare, guided by the organization's purpose of improving health for all individuals, regardless of their financial situation.